Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders

Development of Hematopoietic Stem and Progenitor Cells From Human Pluripotent Stem Cells

(2015) Tong Chen et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

CDK1 Inhibition Targets the p53-NOXA-MCL1 Axis, Selectively Kills Embryonic Stem Cells, and Prevents Teratoma Formation

(2015) Noelle E. Huskey et al.   Stem Cell Reports

Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience

(2014) Philippe Menasché et al.   EUROPEAN HEART JOURNAL

Inhibition of DNA Topoisomerase II Selectively Reduces the Threat of Tumorigenicity Following Induced Pluripotent Stem Cell-Based Myocardial Therapy

(2014) Saranya P. Wyles et al.   STEM CELLS AND DEVELOPMENT

Induced pluripotent stem cells in hematology: current and future applications

(2014) D Focosi et al.   Blood Cancer Journal

‘Above all, do no harm’: safeguarding pluripotent stem cell therapy against iatrogenic tumorigenesis

(2014) Marek Malecki   Stem Cell Research & Therapy

Metabolic Correction of Congenital Erythropoietic Porphyria with iPSCs Free of Reprogramming Factors

(2013) Aurélie Bedel et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Treat cancers by targeting survivin: Just a dream or future reality?

(2013) Mohane Selvaraj Coumar et al.   CANCER TREATMENT REVIEWS

FGFR3 has tumor suppressor properties in cells with epithelial phenotype

(2013) Marie Lafitte et al.   Molecular Cancer

Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies

(2013) Andrew S Lee et al.   NATURE MEDICINE

Inhibition of pluripotent stem cell-derived teratoma formation by small molecules

(2013) M.-O. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Optimized Surface Markers for the Prospective Isolation of High-Quality hiPSCs using Flow Cytometry Selection

(2013) Ramzey Abujarour et al.   Scientific Reports

Protecting against wayward human induced pluripotent stem cells with a suicide gene

(2012) Fuyi Cheng et al.   BIOMATERIALS

In vivo gene transfer targeting in pancreatic adenocarcinoma with cell surface antigens

(2012) Marie Lafitte et al.   Molecular Cancer

The promise of induced pluripotent stem cells in research and therapy

(2012) Daisy A. Robinton et al.   NATURE

Effects of cell number on teratoma formation by human embryonic stem cells

(2011) Andrew S. Lee et al.   CELL CYCLE

Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response

(2011) I. Lipchina et al.   GENES & DEVELOPMENT

Safeguarding Nonhuman Primate iPS Cells With Suicide Genes

(2011) Bonan Zhong et al.   MOLECULAR THERAPY

TK.007: A Novel, Codon-Optimized HSVtk(A168H) Mutant for Suicide Gene Therapy

(2010) Ellen Preuß et al.   HUMAN GENE THERAPY

Teratomas from pluripotent stem cells: A clinical hurdle

(2010) Chui-Yee Fong et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Teratoma formation by human embryonic stem cells: Evaluation of essential parameters for future safety studies

(2009) Hannes Hentze et al.   Stem Cell Research

The Postischemic Environment Differentially Impacts Teratoma or Tumor Formation After Transplantation of Human Embryonic Stem Cell-Derived Neural Progenitors

(2009) Christine Seminatore et al.   STROKE

Neuron-like Differentiation and Selective Ablation of Undifferentiated Embryonic Stem Cells Containing Suicide Gene with Oct-4 Promoter

(2008) Akira Hara et al.   STEM CELLS AND DEVELOPMENT